drugset / Trial / NCT00929734

Effect of Rosuvastatin Therapy in Patients With Stable Chronic Obstructive Pulmonary Disease

NCT00929734

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to investigate whether rosuvastatin improves measures of endothelial function, decreases measures of inflammation, and improves pulmonary function in patients with stable chronic obstructive pulmonary disease.

Timeline

Start
2010-03
Primary completion
2014-01
Completion
2014-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Rosuvastatin Small molecule 10 mg